# Intrapleural Ropivacaine Infusion in Cardiac Surgery

Study · id `cardio:ct-nct07116343` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07116343](<https://clinicaltrials.gov/study/NCT07116343>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07116343

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.

## Technical summary

Registry record NCT07116343. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-22 (actual); primary completion 2027-09-25 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 116 participants (planned count; ClinicalTrials.gov record NCT07116343, source copy `cardio:ctgov-nct07116343-2026-03-10`, retrieved 2026-10-26)
- Started: 2025-10-22 (actual) (ClinicalTrials.gov record NCT07116343, source copy `cardio:ctgov-nct07116343-2026-03-10`, retrieved 2026-10-26)
- Primary completion: 2027-09-25 (anticipated) (ClinicalTrials.gov record NCT07116343, source copy `cardio:ctgov-nct07116343-2026-03-10`, retrieved 2026-10-26)
- Completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT07116343, source copy `cardio:ctgov-nct07116343-2026-03-10`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT07116343, source copy `cardio:ctgov-nct07116343-2026-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07116343-2026-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intrapleural Ropivacaine Infusion in Cardiac Surgery
- Acronym: IRICS
- Condition: Cardiac Surgery
- Condition: Coronary Artery Disease
- Condition: Valvular Diseases
- Intervention (Drug): Ropivacaine
- Intervention (Drug): 0.9 % NaCl
- Lead sponsor: Saint Petersburg State University, Russia
- Lead sponsor class: OTHER
- Collaborator: Primorsky Regional Clinical Hospital No. 1
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 24f83c0b025505a13bec7928d690d4c0ed4130f8e8a9e2196883fa0ced904386
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
